Free Trial

CONMED (CNMD) Stock Price, News & Analysis

$71.01
+0.41 (+0.58%)
(As of 07/26/2024 ET)
Today's Range
$70.32
$71.71
50-Day Range
$64.15
$77.81
52-Week Range
$61.05
$133.57
Volume
412,277 shs
Average Volume
521,185 shs
Market Capitalization
$2.19 billion
P/E Ratio
27.21
Dividend Yield
1.13%
Price Target
$102.33

CONMED MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
44.1% Upside
$102.33 Price Target
Short Interest
Bearish
13.15% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.65mentions of CONMED in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$446,733 Bought Last Quarter
Proj. Earnings Growth
28.14%
From $4.30 to $5.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.94 out of 5 stars

Medical Sector

15th out of 936 stocks

Electromedical Equipment Industry

2nd out of 22 stocks

CNMD stock logo

About CONMED Stock (NYSE:CNMD)

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock Price History

CNMD Stock News Headlines

CONMED (CNMD) Set to Announce Quarterly Earnings on Wednesday
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
CONMED Corporation (CNMD)
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
CONMED First Quarter 2024 Earnings: Beats Expectations
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/26/2023
Ex-Dividend for 7/5 Dividend
6/14/2024
Dividend Payable
7/05/2024
Today
7/26/2024
Next Earnings (Confirmed)
7/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Employees
4,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$102.33
High Stock Price Target
$141.00
Low Stock Price Target
$75.00
Potential Upside/Downside
+44.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$64.46 million
Pretax Margin
8.23%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$6.00 per share
Book Value
$27.13 per share

Miscellaneous

Free Float
28,707,000
Market Cap
$2.18 billion
Optionable
Optionable
Beta
1.42
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


CNMD Stock Analysis - Frequently Asked Questions

How have CNMD shares performed this year?

CONMED's stock was trading at $109.51 at the beginning of 2024. Since then, CNMD shares have decreased by 35.2% and is now trading at $71.01.
View the best growth stocks for 2024 here
.

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) posted its quarterly earnings data on Wednesday, July, 26th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.04. The firm's quarterly revenue was up 14.6% compared to the same quarter last year.

Who are CONMED's major shareholders?

Top institutional shareholders of CONMED include Mountain Pacific Investment Advisers LLC (0.47%), M&G Plc (0.43%), Portman Square Capital LLP and Kempner Capital Management Inc. (0.30%). Insiders that own company stock include Daniel S Jonas, Pat Beyer, Brian Concannon, Curt R Hartman, Peter K Shagory, Barbara J Schwarzentraub, Johonna Marie Pelletier, John D Ferrell, Stanley W Peters III and Todd W Garner.
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CNMD) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners